ecteinascidin 743 has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balaná, C; Bendszus, M; Bonneville-Levard, A; Brandal, P; Brazil, L; Bromberg, J; Bronnimann, C; Bruna, J; Cameron, A; Clement, PM; Coens, C; Ducray, F; Dumont, S; Erridge, S; Furtner, J; Golfinopoulos, V; Gorlia, T; Le Rhun, E; Lefranc, F; Lewis, J; Lombardi, G; Lorgis, V; Mair, MJ; Marosi, C; Mawrin, C; Pichler, J; Preusser, M; Reijneveld, JC; Sahm, F; Sanson, M; Sepulveda, JM; Sievers, P; Silvani, A; Soffietti, R; Thon, N; Vauleon, E; Weller, M; Wick, W | 1 |
| Alvarez-Breckenridge, CA; Brastianos, PK; Cahill, DP | 1 |
1 trial(s) available for ecteinascidin 743 and Brain Neoplasms
| Article | Year |
|---|---|
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
Topics: Adult; Brain Neoplasms; Disease-Free Survival; Humans; Meningeal Neoplasms; Meningioma; Quality of Life; Trabectedin; World Health Organization | 2022 |
1 other study(ies) available for ecteinascidin 743 and Brain Neoplasms
| Article | Year |
|---|---|
Trabectedin for recurrent WHO grade 2 or 3 meningiomas-Paving the road for new opportunities.
Topics: Brain Neoplasms; Humans; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Trabectedin; World Health Organization | 2022 |